Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Iris K, Sokka"'
Autor:
Jelena Matović, Juulia Järvinen, Iris K. Sokka, Surachet Imlimthan, Olli Aitio, Mirkka Sarparanta, Jarkko Rautio, Filip S. Ekholm
Publikováno v:
Molecules, Vol 29, Iss 17, p 4263 (2024)
Boron Neutron Capture Therapy (BNCT) is a cancer treatment which combines tumor-selective boron delivery agents with thermal neutrons in order to selectively eradicate cancer cells. In this work, we focus on the early-stage development of carbohydrat
Externí odkaz:
https://doaj.org/article/9c47b19bd5b341ce9b2e8aff4ce2ab60
Autor:
Jelena Matović, Katayun Bahrami, Philipp Stockmann, Iris K. Sokka, You Cheng Khng, Mirkka Sarparanta, Evamarie Hey-Hawkins, Jarkko Rautio, Filip S. Ekholm
Publikováno v:
Molecular Pharmaceutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c1e4a225677d7dd5243d38b06858293
https://doi.org/10.1021/acs.molpharmaceut.3c00119
https://doi.org/10.1021/acs.molpharmaceut.3c00119
Autor:
Jelena Matović, Juulia Järvinen, Iris K. Sokka, Philipp Stockmann, Martin Kellert, Surachet Imlimthan, Mirkka Sarparanta, Mikael P. Johansson, Evamarie Hey-Hawkins, Jarkko Rautio, Filip S. Ekholm
Glucose-and sodium-dependent glucose transporters (GLUTs and SGLTs) play vital roles in human biology. Of the 14 GLUTs and 12 SGLTs, the GLUT1 transporter has gained t h e most widespread recognition because GLUT1 is overexpressed in several cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f817c06505986eb7aff16321321477a
http://hdl.handle.net/10138/350550
http://hdl.handle.net/10138/350550
Autor:
Jelena, Matović, Juulia, Järvinen, Iris K, Sokka, Philipp, Stockmann, Martin, Kellert, Surachet, Imlimthan, Mirkka, Sarparanta, Mikael P, Johansson, Evamarie, Hey-Hawkins, Jarkko, Rautio, Filip S, Ekholm
Publikováno v:
ACS omega. 7(34)
Glucose- and sodium-dependent glucose transporters (GLUTs and SGLTs) play vital roles in human biology. Of the 14 GLUTs and 12 SGLTs, the GLUT1 transporter has gained the most widespread recognition because GLUT1 is overexpressed in several cancers a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::605ee06346d03ebe3fa17fea2d7cda23
https://pubmed.ncbi.nlm.nih.gov/36061667
https://pubmed.ncbi.nlm.nih.gov/36061667
Autor:
Jelena, Matović, Juulia, Järvinen, Iris K, Sokka, Surachet, Imlimthan, Jan-Erik, Raitanen, Ahmed, Montaser, Hannu, Maaheimo, Kristiina M, Huttunen, Sirpa, Peräniemi, Anu J, Airaksinen, Mirkka, Sarparanta, Mikael P, Johansson, Jarkko, Rautio, Filip S, Ekholm
Publikováno v:
Molecular pharmaceutics. 18(1)
Boron neutron capture therapy (BNCT) is a noninvasive binary therapeutic modality applicable to the treatment of cancers. While BNCT offers a tumor-targeting selectivity that is difficult to match by other means, the last obstacles preventing the ful
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ecd79b218a7ceb135859713697f1f690
https://pubmed.ncbi.nlm.nih.gov/33390018
https://pubmed.ncbi.nlm.nih.gov/33390018